Skip to content

Announcements - Search results

Search results: Company announcements for
NOVOGEN LIMITED (NRT)
Released between 01/01/2013 and 31/12/2013

Didn't find the announcement you were after? Search again.

Announcements released as NRT

Date Price
sens.
Headline Pages PDF Edited
text*
23/12/2013   Appendix 3B 13 PDF -
23/12/2013   Appendix 3B 14 PDF -
20/12/2013 asterix Novogen Announces Establishment of Global Collaboration 3 PDF -
19/12/2013   Novogen to Present at Biotech Showcase in San Francisco 1 PDF -
06/12/2013   Change of Director's Interest Notice 3 PDF -
06/12/2013   Company Secretary resignation 1 PDF -
26/11/2013 asterix Novogen files patents for anti-tropomyosin drug technology 2 PDF -
25/11/2013 asterix Trilexium Destroys Ovarian Cancer Stem Cell Spheroids 2 PDF -
21/11/2013   Change of Director's Interest Notice 3 PDF -
20/11/2013   Appendix 3B 13 PDF -
20/11/2013   Cleansing Notice 1 PDF -
18/11/2013   Appendix 3B 14 PDF -
15/11/2013   Results of Meeting 2 PDF -
15/11/2013 asterix Issue of Convertible Note 1 PDF -
14/11/2013 asterix Novogen Announces Important Discovery 3 PDF -
11/11/2013   Appendix 3B 13 PDF -
11/11/2013   Cleansing Notice 1 PDF -
07/11/2013   Appendix 3B 13 PDF -
07/11/2013   Cleansing Notice 1 PDF -
07/11/2013   Appendix 3B 13 PDF -
07/11/2013   Cleansing Notice 1 PDF -
07/11/2013   Press release relative to new joint venture 3 PDF -
07/11/2013 asterix Novogen Announces Joint Venture 3 PDF -
05/11/2013   Appendix 3B 13 PDF -
05/11/2013   Cleansing Notice 1 PDF -
01/11/2013   Cleansing notice 1 PDF -
01/11/2013   Appendix 3B 13 PDF -
30/10/2013   Company Secretary Appointment 1 PDF -
22/10/2013   Appendix 3B 14 PDF -
21/10/2013 asterix Purchase of Convertible Security 1 PDF -
16/10/2013 asterix Novogen comments on recent share price rise 1 PDF -
16/10/2013   Trading Halt Request 1 PDF -
16/10/2013 asterix Trading Halt 1 PDF -
09/10/2013   Cleansing Notice 1 PDF -
09/10/2013 asterix New technology to add to oncology drug pipeline 2 PDF -
08/10/2013   Appendix 3B 13 PDF -
08/10/2013   Notice of Annual General Meeting / Proxy Form 30 PDF -
26/09/2013   Annual Report to shareholders 89 PDF -
17/09/2013   Cleansing Notice 1 PDF -
16/09/2013   Appendix 3B 13 PDF -
05/09/2013   Cleansing Notice and Appendix 3B 14 PDF -
03/09/2013   Cleansing Notice 1 PDF -
02/09/2013   Appendix 3B 13 PDF -
30/08/2013 asterix Appendix 4E and Preliminary Final Report 22 PDF -
30/08/2013   Change in substantial holding 5 PDF -
29/08/2013   Cleansing Notice 1 PDF -
27/08/2013   Appendix 3B 13 PDF -
22/08/2013   Cleansing Notice and Appendix 3B 14 PDF -
14/08/2013   Cleansing Notice and Appendix 3B 14 PDF -
09/08/2013   Cleansing Statement 1 PDF -
08/08/2013   Appendix 3B 13 PDF -
07/08/2013   Appointment of Chairman of Medical Advisory Board 2 PDF -
30/07/2013   Cleansing Notice 1 PDF -
26/07/2013   Appendix 3B 13 PDF -
05/07/2013   Appendix 3B 14 PDF -
04/07/2013   Cleansing Statement and Appendix 3B 14 PDF -
04/07/2013 asterix Funding Arrangement 2 PDF -
03/07/2013 asterix Trading Halt 2 PDF -
02/07/2013   Change of Director's Interest Notice x 3 10 PDF -
28/06/2013   Appendix 3B 12 PDF -
27/06/2013   Explanatory Notice for shareholders who hold stock in MEIP 2 PDF -
03/06/2013   Change of Director's Interest Notice x 4 10 PDF -
03/06/2013   Cleansing Statement 1 PDF -
29/05/2013   Novogen CEO to speak at Investor Forum 2 PDF -
29/05/2013   Novogen Announces SPP Outcome 2 PDF -
29/05/2013   Results of Share Purchase Plan & Appendix 3B 13 PDF -
23/05/2013   Becoming a substantial holder 5 PDF -
10/05/2013   Extension of Share Purchase Plan 1 PDF -
07/05/2013 asterix Novogen Oncology Discovery Library and Indications Expand 2 PDF -
07/05/2013   Novogen Announces New Executive Appointments 2 PDF -
07/05/2013   Change of Registered Office 1 PDF -
02/05/2013   Change in substantial holding 5 PDF -
01/05/2013   Cleansing Statement 1 PDF -
29/04/2013   Appendix 3B 12 PDF -
29/04/2013   Amended Final Director's Interest Notice 2 PDF -
22/04/2013   Final Director's Interest Notice 2 PDF -
19/04/2013   Results of General Meeting 2 PDF -
19/04/2013   Chairman's Address and Proxy Votes 47 PDF -
19/04/2013   Novogen Director Steps Down 2 PDF -
17/04/2013   Share Purchase Plan - option holders' participation 2 PDF -
17/04/2013 asterix Share Purchase Plan 27 PDF -
17/04/2013   Share Purchase Plan Cleansing Notice 2 PDF -
17/04/2013   Novogen releases newsletter to coincide with General Meeting 9 PDF -
12/04/2013 asterix Novogen announces placement of stock to raise $2.5M 2 PDF -
11/04/2013 asterix Trading Halt 2 PDF -
08/04/2013 asterix Successful Isolation of Most Potent Form of CS-6 2 PDF -
08/04/2013   Investor Presentation 16 PDF -
03/04/2013 asterix Potency of CS-6 Confirmed 2 PDF -
20/03/2013   Notice of General Meeting/Proxy Form 22 PDF -
06/03/2013 asterix MOU Signed with The Ingham Institute 2 PDF -
28/02/2013 asterix Half Yearly Report and Accounts - Appendix 4D 25 PDF -
21/02/2013   Novogen demerger tax implications 1 PDF -
18/02/2013   Becoming a substantial holder 2 PDF -
18/02/2013   Change of Director's Interest Notice x 3 8 PDF -
18/02/2013 asterix CS-6 Highly Active Against Ovarian Cancer Stem Cells 2 PDF -
15/02/2013   Change in substantial holding 5 PDF -
13/02/2013   Cleansing Statement and Appendix 3B 14 PDF -
05/02/2013 asterix Novogen Announces Filing of Key Patent Application 2 PDF -
05/02/2013 asterix Allocation of Shares to Triaxial Pharmaceutical Shareholders 2 PDF -

Useful Information

Didn't find the announcement you were after? Search again.

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.